AGIO — Agios Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.21bn
- $1.59bn
- $54.03m
Agios Pharma jumps after US FDA expands use of co's drug for blood disorder
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
Agios Pharma rises after US FDA expands use of co's drug for blood disorder
NASDAQ RESUMED AT 07:10 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
Brief: US FDA Approves Agios’ Aqvesme (Mitapivat) For Treatment Of Anemia In Adults With Alpha- Or Beta-Thalassemia
NASDAQ TRADE HALT HALT NEWS PENDING AT 05:59 PM
U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart
Buzz Us Stocks On The Move: Tesla, Warner Bros Discovery, Netflix
U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix
Brief: Agios Pharmaceuticals Says FDA Has Not Issued Decision On Agios' sNDA for Mitapivat
Agios Pharma falls after FDA misses decision deadline on blood-disorder drug filing
U.S. STOCKS ON THE MOVE-Apollo Global, Exact Sciences, Eaton
U.S. STOCKS ON THE MOVE-Oddity Tech, Central Bancompany, Shoe Carnival
U.S. RESEARCH ROUNDUP- Agios Pharmaceuticals, Dycom Industries, Lowe's Companies
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet
Agios shares tumble on mixed results for sickle cell drug trial (updated)
U.S. STOCKS ON THE MOVE-Constellation Energy, Williams-Sonoma
U.S. STOCKS ON THE MOVE-Lowe's, TJX Companies, Target